Numerous studies have demonstrated a deregulation of mTOR pathway in DS (Bacalini et al., 2015; Perluigi & Butterfield, 2012) and have linked the alterations of mTOR pathway to cognitive decline, AD, and AD‐like dementia in DS (Di Domenico et al., 2018). The gene discussed is MTOR; the disease is dementia.